迈向消除宫颈癌——亚洲国家癌症中心联盟（ANCCA）成员国的人乳头瘤病毒（HPV）疫苗接种与宫颈癌筛查
Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries.
作者信息
Ong Sok King, Abe Sarah K, Thilagaratnam Shyamala, Haruyama Rei, Pathak Ruchi, Jayasekara Harindra, Togawa Kayo, Bhandari Aliza K C, Shankar Abhishek, Nessa Ashrafun, Jugder Uranbolor, Agustina Julyanti, Biglari Mohammed, Yusuf Aasim, Tshomo Ugyen, Fernando Eshani, Cairo Clarito, Kaung Kyaw Kan, Rath Beauta, Vongdala Champadeng, Pradhananga Kishore Kumar, Kim Jeongseon, Chung Youn Kyung, Thanh Huong Tran Thi, Sangrajran Suleeporn, Zhang Yawei, Basu Partha, Woo Yin Ling, Sukumaran Babu, Hwang William Y K
机构信息
PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam.
National Cancer Center Institute for Cancer Control, Tokyo, Japan.
出版信息
Lancet Reg Health West Pac. 2023 Aug 1;39:100860. doi: 10.1016/j.lanwpc.2023.100860. eCollection 2023 Oct.
About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV). Cervical cancer is preventable and curable if it is detected and treated early. We reviewed the latest national cervical cancer indicators, and barriers to HPV vaccination and cervical cancer screening in 21 Asian National Cancer Centers Alliance (ANCCA) member countries. Half (n = 11, 52%) of the countries have introduced HPV vaccination for girls as part of their national vaccination programme, three countries reported coverage of over 90%. Most ANCCA member countries have cervical cancer screening programmes, only five countries reported screening uptake of over 50%. The barriers to HPV vaccination coverage and cervical cancer screening participation have been identified. Ensuring health service accessibility and affordability for women, addressing sociocultural barriers, and strengthening the healthcare system and continuum of care are essential to increase HPV vaccination and cervical cancer screening coverage.
全球约95%的宫颈癌是由人乳头瘤病毒（HPV）引起的。宫颈癌如果能早期发现并治疗，是可预防且可治愈的。我们回顾了21个亚洲国家癌症中心联盟（ANCCA）成员国的最新国家宫颈癌指标，以及HPV疫苗接种和宫颈癌筛查的障碍。一半（n = 11，52%）的国家已将女孩HPV疫苗接种纳入其国家疫苗接种计划，三个国家报告接种率超过90%。大多数ANCCA成员国都有宫颈癌筛查计划，只有五个国家报告筛查接受率超过50%。已确定HPV疫苗接种覆盖率和宫颈癌筛查参与率的障碍。确保妇女获得可及且负担得起的医疗服务、解决社会文化障碍以及加强医疗保健系统和连续护理对于提高HPV疫苗接种率和宫颈癌筛查覆盖率至关重要。
Zotero 插件